278
Views
17
CrossRef citations to date
0
Altmetric
Review

Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy

Pages 481-490 | Published online: 14 Sep 2012

References

  • HamiltonBEMartinJAVenturaSJBirths: preliminary data for 2010Natl Vital Stat Rep20116012622670489
  • MathewsTJMacDormanMFInfant mortality statistics from the 2008 period linked birth/infant death data setNatl Vital Stat Rep20126014922670489
  • SaigalSDoyleLWAn overview of mortality and sequelae of preterm birth from infancy to adulthoodLancet200837126126918207020
  • McCormickMCLittJSSmithVCZupancicJAFPrematurity: an overview and public health implicationsAnn Rev Public Health20113236737921219170
  • RussellRBGreenNSSteinerCACost of hospitalization for preterm and low birth weight infants in the United StatesPediatrics2007120e1e917606536
  • National Research CouncilPreterm birth: causes, consequences, and preventionBehrmanREButlerASCommittee on Understanding Premature Birth Assuring Healthy OutcomesWashington, DCThe National Academies Press2007
  • March of Dimes FoundationMedical costs for one premature baby could cover a dozen healthy births3172009 Available from: http://www.eurekalert.org/pub_releases/2009-03/modf-mcf031309.phpAccessed on August 1, 2012
  • HeathVCSouthallTRSoukaAPElisseouANicolaidesKHCervical length at 23 weeks of gestation: prediction of spontaneous preterm deliveryUltrasound Obstet Gynecol1998123123179819868
  • AndersenHFNugentCEWantySDHayashiRHPrediction of risk for preterm delivery by ultrasonographic measurement of cervical lengthAm J Obstet Gynecol19901638598672206073
  • IamsJDGoldenbergRLMeisPJThe length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit NetworkN Engl J Med19963345675728569824
  • TaipalePHiilesmaaVSonographic measurement of uterine cervix at 18–22 weeks’ gestation and the risk of preterm deliveryObstet Gynecol1998929029079840546
  • RossMGCousinsLBaxter-JonesRBemis-HeysRCatanzariteVDowlingDObjective cervical portio length measurements: consistency and efficacy of screening for a short cervixJ Reprod Med20075238538917583236
  • AndersenHFTransvaginal and transabdominal ultrasonography of the uterine cervix during pregnancyJ Clin Ultrasound19911977831847952
  • OkitsuOMimuraTNakayamaTAonoTEarly prediction of preterm delivery by transvaginal ultrasonographyUltrasound Obstet Gynecol1992240240912796914
  • HeathVCSouthallTRSoukaAPNovakovANicolaidesKHCervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric historyUltrasound Obstet Gynecol1998123043119819867
  • ClementSCandyBHeathVToMNicolaidesKHTransvaginal ultrasound in pregnancy: its acceptability to women and maternal psychological morbidityUltrasound Obstet Gynecol20032250851414618665
  • OlatunbosunOAal-NuaimLTurnellRWEmergency cerclage compared with bed rest for advanced cervical dilatation in pregnancyInt Surg1995801701748530237
  • ArisoyRYaylaMTransvaginal sonographic evaluation of the cervix in asymptomatic singleton pregnancy and management options in short cervixJ Pregnancy201220162822
  • LockwoodCThe real progesterone story: Exploring the Makena drug controversyContemp Ob/Gyn2011561014
  • CampbellSUniversal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an optionUltrasound Obstet Gynecol2011381921713990
  • CombsCAVaginal progesterone for asymptomatic cervical shortening and the case for universal screening of cervical lengthAm J Obstet Gynecol201220610110322284154
  • Society for Maternal-Fetal Medicine Publications CommitteeProgesterone and preterm birth prevention: translating clinical trials data into clinical practiceAm J Obstet Gynecol201220637638622542113
  • CahillAGOdiboAOCaugheyABUniversal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysisAm J Obstet Gynecol2010202548. e1e820079888
  • WernerEFHanCSPettkerCMUniversal cervical-length screening to prevent preterm birth: a cost-effectiveness analysisUltrasound Obstet Gynecol201138323721157771
  • IamsJDJohnsonFFSonekJSachsLGebauerCSamuelsPCervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performanceAm J Obstet Gynecol199517210971103 discussion, 104–1067726247
  • BerghellaVRomanADaskalakisCNessABaxterJKGestational age at cervical length measurement and incidence of preterm birthObstet Gynecol200711031131717666605
  • DeFrancoEAO’BrienJMAdairCDVaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trialUltrasound Obstet Gynecol20073069770517899571
  • da FonsecaEBCelikEParraMSinghMNicolaidesKHProgesterone and the risk of preterm birth among women with a short cervixN Engl J Med200735746246917671254
  • HassanSSRomeroRVidyadhariDVaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trialUltrasound Obstet Gynecol201138183121472815
  • RomeroRNicolaidesKConde-AgudeloAVaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient dataAm J Obstet Gynecol2012206124. e1e1922284156
  • OwenJHankinsGIamsJDMulticenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical lengthAm J Obstet Gynecol2009201375. e1e819788970
  • SchumacherMSitruk-WareRDe NicolaAFProgesterone and progestins: neuroprotection and myelin repairCurr Opin Pharmacol2008874074618929681
  • GoletianiNVKeithDRGorskySJProgesterone: Review of safety for clinical studiesExper Clin Psychopharmacol20071542744417924777
  • XuHGonzalezJMOforiEElovitzMAPreventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?Am J Obstet Gynecol2008198314. e1314e818313454
  • de LignieresBOral micronized progesteroneClin Ther1999214160 discussion 1–210090424
  • CicinelliEde ZieglerDBullettiCMatteoMGSchonauerLMGalantinoPDirect transport of progesterone from vagina to uterusObstet Gynecol20009540340610711552
  • FanchinRMDe ZieglerDMBergeronCPRighiniCMTorrisiCMFrydmanRMTransvaginal administration of progesteroneObstet Gynecol1997903964019277651
  • SfakianakiAKNorwitzERMechanisms of progesterone action in inhibiting prematurityJ Matern Fetal Neonatal Med20061976377217190686
  • DayaSLuteal support: progestogens for pregnancy protectionMaturitas200965Suppl 1S29S3419913373
  • WahabiHAAbed AlthagafiNFElawadMAl ZeidanRAProgestogen for treating threatened miscarriageCochrane Database Syst Rev201112CD00594322161393
  • da FonsecaEBBittarRECarvalhoMHProphylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. [see comment.]Am J Obstet Gynecol200318841942412592250
  • SuL-LSamuelMChongYSProgestational agents for treating threatened or established preterm labourCochrane Database Syst Rev20101CD00677020091604
  • RomeroRPrevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatmentUltrasound Obstet Gynecol20073067568617899585
  • WordRALiX-HHnatMCarrickKDynamics of cervical remodeling during pregnancy and parturition: mechanisms and current conceptsSemin Reprod Med200725697917205425
  • YellonSMBurnsAESeeJLLechugaTJKirbyMAProgesterone withdrawal promotes remodeling processes in the nonpregnant mouse cervixBiol Reprod2009811619228593
  • ChwaliszKThe use of progesterone antagonists for cervical ripening and as an adjunct to labour and deliveryHum Reprod19949Suppl 11311617962460
  • JeschkeUMylonasIRichterD-URegulation of progesterone production in human term trophoblasts in vitro by CRH, ACTH and cortisol (prednisolone)Arch Gynecol Obstet200527271215834733
  • MeisPJKlebanoffMThomEPrevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproateN Engl J Med20033482379238512802023
  • O’BrienJMAdairCDLewisDFProgesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trialUltrasound Obstet Gynecol20073068769617899572
  • CetingozECamCSakalliMKaratekeACelikCSancakAProgesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trialArch Gynecol Obstet201128342342920091317
  • RodeLKleinKNicolaidesKHKrampl-BettelheimETaborAfor the PREDICT GroupPrevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesteroneUltrasound Obstet Gynecol20113827228021739497
  • ToMSSkentouCARoystonPYuCKHNicolaidesKHPrediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective studyUltrasound Obstet Gynecol20062736236716565989
  • ZarutskiePWPhillipsJAA meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesteroneFertil Steril20099216316919362303
  • PolyzosNPMessiniCIPapanikolaouEGVaginal progesterone gel for luteal phase support in IVF/ICSI cycles: a meta-analysisFertil Steril2010942083208720171629
  • MilesRAPaulsonRJLoboRAPressMFDahmoushLSauerMVPharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative studyFertil Steril1994624854908062942
  • GermondMCapelliPBrunoGComparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilizationFertil Steril20027731331711821089
  • KleinsteinJLuteal Phase Study GEfficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproductionFertil Steril2005831641164915950631
  • HaasDMRamseyPSProgestogen for preventing miscarriageCochrane Database Sys Rev2008CD003511
  • KatzZLancetMSkornikJChemkeJMogilnerBMKlinbergMTeratogenicity of progestogens given during the first trimester of pregnancyObstet Gynecol1985657757803158848
  • O’BrienJMSteichenJJPhillipsJACreasyGW490: Two year infant outcomes for children exposed to supplemental intravaginal progesterone gel in utero: secondary analysis of a multicenter, randomized, double-blind, placebo-controlled trialAm J Obstet Gynecol2012206S223
  • SimunicVTomicVTomicJNizicDComparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal supportFertil Steril200787838717081536
  • LudwigMSchwartzPBabahanBLuteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized studyEur J Obstet Gynecol Reprod Biol2002103485212039463
  • YanushpolskyEHurwitzSGreenbergLRacowskyCHornsteinMCrinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilizationembryo transfer cycles: a prospective randomized studyFertil Steril2010942596259920347079
  • ShamanskySLClausenCLLevels of prevention: examination of the conceptNurs Outlook1980281041086898305
  • RamaekerDMSimhanHNSonographic cervical length, vaginal bleeding, and the risk of preterm birthAm J Obstet Gynecol2012206224. e1e422133802
  • MercerBMGoldenbergRLDasAThe preterm prediction study: a clinical risk assessment systemAm J Obstet Gynecol199617418851893 discussion, 93–958678155
  • HonestHBachmannLMSundaramRGuptaJKKleijnenJKhanKSThe accuracy of risk scores in predicting preterm birth – a systematic reviewJ Obstet Gynaecol20042434335915203570
  • LeitichHEgarterCKaiderAHohlagschwandtnerMBerghammerPHussleinPCervicovaginal fetal f ibronectin as a marker for preterm delivery: a meta-analysisAm J Obstet Gynecol19991801169117610329873
  • YangJHartmannKESavitzDAVaginal bleeding during pregnancy and preterm birthAm J Epidemiol200416011812515234932
  • GoldenbergRLCulhaneJFIamsJDRomeroREpidemiology and causes of preterm birthLancet2008371758418177778
  • MandalDMandaSRakshiADeyRPBiswasSCBanerjeeAMaternal obesity and pregnancy outcome: a prospective analysisJ Assoc Physicians India20115948648921887903
  • SmithGCSPellJPDobbieRInterpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study. [Erratum appears in BMJ. 2003;327(7419):851.]BMJ200332731312907483
  • OforiBDLe TiecMBerardARisk factors associated with preterm birth according to gestational age at birthPharmacoepidemiol Drug Saf20081755656418327870
  • HuaMOdiboAOLongmanREMaconesGARoehlKACahillAGCongenital uterine anomalies and adverse pregnancy outcomesAm J Obstet Gynecol201120522
  • VergnesJ-NSixouMPreterm low birth weight and maternal periodontal status: a meta-analysisAm J Obstet Gynecol2007196135.e1135e717306654
  • HassanSSRomeroRBerrySMPatients with an ultrasonographic cervical length <or=15 mm have nearly a 50% risk of early spontaneous preterm deliveryAm J Obstet Gynecol20001821458146710871466
  • MorozLASimhanHNRate of sonographic cervical shortening and the risk of spontaneous preterm birthAm J Obstet Gynecol2012206234. e1e522189048
  • GrobmanWAfor the Eunice Kennedy Shriver National Institute of Health and Human DevelopmentRandomized controlled trial of progesterone treatment for preterm birth prevention in nulliparous women with cervical length less than 30 mmAm J Obstet Gynecol2012206S367
  • MercerBMGoldenbergRLMoawadAHThe preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. NICHHD MFMU NetworkAm J Obstet Gynecol19991811216122110561648